787 related articles for article (PubMed ID: 16226521)
41. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
42. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
43. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
44. Laser photocoagulation combined with subtenon injection of triamcinolone acetonide for diabetic cystoid macular edema.
Kuo HK; Wu PC; Chen YH; Cheng LS
Chang Gung Med J; 2009; 32(2):172-81. PubMed ID: 19403007
[TBL] [Abstract][Full Text] [Related]
45. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
46. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
47. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
48. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
49. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
50. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
Tunc M; Onder HI; Kaya M
Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
[TBL] [Abstract][Full Text] [Related]
51. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
Negi AK; Vernon SA; Lim CS; Owen-Armstrong K
Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
[TBL] [Abstract][Full Text] [Related]
52. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
[TBL] [Abstract][Full Text] [Related]
53. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Kim SY; Yang J; Lee YC; Park YH
J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
[TBL] [Abstract][Full Text] [Related]
54. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
55. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
56. The response pattern of intravitreal triamcinolone injection for non-AMD macular edema.
Bhurayanontachai P; Ratanasukon M; Ma-a-lee A
J Med Assoc Thai; 2009 Jan; 92(1):58-63. PubMed ID: 19260245
[TBL] [Abstract][Full Text] [Related]
57. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Bobbili RB; Mathai A
Am J Ophthalmol; 2006 Sep; 142(3):531; author reply 531-2. PubMed ID: 16935620
[No Abstract] [Full Text] [Related]
58. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study.
Parodi MB; Iacono P; Ravalico G
Br J Ophthalmol; 2008 Aug; 92(8):1046-50. PubMed ID: 18556425
[TBL] [Abstract][Full Text] [Related]
59. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]